Page last updated: 2024-08-25

bexarotene and Dermatitis

bexarotene has been researched along with Dermatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boezeman, JB; de Jong, EM; Otero, ME; Smit, JV; van de Kerkhof, PC; van Hooijdonk, CA	1

Trials

1 trial(s) available for bexarotene and Dermatitis

Article	Year
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin. Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:2 Topics: Administration, Oral; Adult; Apoptosis; Bexarotene; Biopsy, Needle; Cell Differentiation; Dermatitis; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidermis; Humans; Immunohistochemistry; Keratinocytes; Ki-67 Antigen; Psoriasis; Tetrahydronaphthalenes	2004

Article

Year

Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.

Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:2

Topics: Administration, Oral; Adult; Apoptosis; Bexarotene; Biopsy, Needle; Cell Differentiation; Dermatitis; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidermis; Humans; Immunohistochemistry; Keratinocytes; Ki-67 Antigen; Psoriasis; Tetrahydronaphthalenes

2004